• About the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

    A registered branch of the European Society of Cardiology (ESC)

    Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.

    Who we are

    The EAPCI was created in 2006. Its objectives and activities stem from the synergy between the assets of EuroPCR and the former ESC Working Group on Interventional Cardiology.  Across all its activities, EAPCI aims to foster a close and mature collaboration with industry partners, based on a clearly defined code of conduct. Post-graduate education, improving patient access to device-based therapies and promoting clinical research represent obvious areas of common and shared interest.

    What we do

    • The EAPCI contributes actively to the programme of the yearly EuroPCR Course, which has become its official annual meeting.
    • The EAPCI has another official course: PCR London Valves, focusing on the care of patients with valvular heart disease. 
    • The EuroIntervention Journal  aims to create a community of high-quality research and education in the field of percutaneous and surgical cardiovascular interventions.
    • The PCR-EAPCI Textbook: it is the first of its kind, all-inclusive reference whose scope and content is patient-centred and promotes good, evidence-based clinical practices.
    • A strong involvement in the field of education through the Education and Training Fellowship Programme, 4-weeks observational micro-fellowship standard training programme, the EAPCI Fellows Courses... These activities are the main focus of the Association and are being expanded, in close collaboration with the Interventional Working Groups throughout Europe, and abroad.
    • The EAPCI contributes with enthusiasm to all activities of the ESC, as they pertain to revascularization and other percutaneous interventions, only to name the contributions to ESC Congress, the EURObservational Research Programme (EORP), preparation and implementation of Guidelines.
    • Advocacy activities include Valve for Life Initiative as well as the ongoing collaboration with EU regulators to ensure the safety, relevance and availability of medical devices.
    • Finally, the Association is planning to put a focus on patients, with extended activities around patient involvement, patient reported outcomes and overcoming disparity in access to the diagnostic and therapeutic procedures in PCI.

    For more information, visit the EAPCI website >

Cookies Policy

When you use our website, we may collect information to operate and improve your experience through cookies. By closing or continuing on this site, you agree to this use of cookies. 
For more details, 
consult our full Cookies Policy